BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Oceana Therapeutics 



Edison  New Jersey    U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS


Industry
Pharmaceutical

Segment
Start Up





 Company News
Salix Pharmaceuticals, Ltd. (SLXP) Completes Acquisition of Oceana Therapeutics 12/21/2011 5:57:56 AM    More...
Salix Pharmaceuticals, Ltd. (SLXP) to Acquire Oceana Therapeutics for $300 Million 11/9/2011 6:17:51 AM    More...
Oceana Therapeutics Announces U.S. Launch of Solesta®, The Only Nonsurgical FDA Approved Treatment for Patients Who Fail Conservative Therapy for Fecal (Bowel) Incontinence 9/6/2011 11:10:18 AM    More...
FDA Approves Oceana Therapeutics's Solesta(R); Novel Specialty Therapeutic Addresses Large Treatment Void for Patients with Life-Altering Fecal (Bowel) Incontinence 5/31/2011 6:30:24 AM    More...
Oceana Therapeutics Announces Strategic Alliance Providing Dr. Reddy's Laboratories Ltd. (RDY) Rights to Deflux® in India 5/16/2011 10:10:24 AM    More...
Oceana Therapeutics Gets FDA Approvable Letter for Solesta(R), a Significant Treatment Option for Fecal (Bowel) Incontinence; the Only Minimally Invasive Therapy for More Severe Bowel Control Problems 4/7/2011 7:21:33 AM    More...
Oceana Therapeutics Announces FDA Advisory Committee Recommends Approval of Solesta(TM) for Fecal (Bowel) Incontinence 12/3/2010 8:15:43 AM    More...
Oceana Therapeutics Announces Andrew J. Einhorn Named 2010 NJBIZ CFO of the Year for Company Growth 10/28/2010 11:51:16 AM    More...
Oceana Therapeutics Announces Andrew J. Einhorn Honored as Finalist in the 2010 NJBIZ CFO of the Year Awards Program 9/13/2010 12:53:48 PM    More...
Oceana Therapeutics Announces John T. Spitznagel Named to PharmaVOICE’s 100 Most Inspiring People in the Life Sciences 8/19/2010 9:02:19 AM    More...
12

//-->